Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 13, 2023

BUY
$36.12 - $41.79 $15,098 - $17,468
418 Added 2.36%
18,115 $664,000
Q1 2023

Apr 19, 2023

BUY
$39.39 - $51.28 $6,026 - $7,845
153 Added 0.87%
17,697 $722,000
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $1,962 - $2,561
47 Added 0.27%
17,544 $899,000
Q3 2022

Nov 07, 2022

SELL
$43.76 - $53.42 $41,046 - $50,107
-938 Reduced 5.09%
17,497 $766,000
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $11,260 - $13,351
242 Added 1.33%
18,435 $912,000
Q1 2022

Apr 29, 2022

SELL
$45.75 - $56.69 $20,221 - $25,056
-442 Reduced 2.37%
18,193 $942,000
Q4 2021

Feb 15, 2022

BUY
$41.32 - $61.25 $20,618 - $30,563
499 Added 2.75%
18,635 $1.1 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $11,186 - $14,369
285 Added 1.6%
18,136 $780,000
Q2 2021

Nov 12, 2021

BUY
$35.91 - $40.68 $42,768 - $48,449
1,191 Added 7.15%
17,851 $699,000
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $4,822 - $5,438
-144 Reduced 0.86%
16,660 $604,000
Q4 2020

Feb 18, 2021

BUY
$33.47 - $42.56 $401,372 - $510,379
11,992 Added 249.21%
16,804 $619,000
Q3 2020

Nov 16, 2020

BUY
$31.75 - $37.25 $43,084 - $50,548
1,357 Added 39.28%
4,812 $177,000
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $24,849 - $30,145
825 Added 31.37%
3,455 $113,000
Q1 2020

May 18, 2020

BUY
$27.03 - $38.62 $71,088 - $101,570
2,630 New
2,630 $87,000
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $97,410 - $110,548
-2,959 Closed
0 $0
Q1 2019

May 28, 2020

SELL
$37.5 - $41.2 $22,500 - $24,720
-600 Reduced 16.86%
2,959 $126,000
Q4 2018

May 28, 2020

BUY
$38.47 - $43.86 $8,848 - $10,087
230 Added 6.91%
3,559 $155,000
Q1 2018

May 28, 2020

BUY
$31.91 - $37.02 $106,228 - $123,239
3,329 New
3,329 $119,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Capital Advisory Group Advisory Services, LLC Portfolio

Follow Capital Advisory Group Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.